Synaptogenix Inc (SNPX)

[Cyosol]

The calculation is flawed and so is the market. I'm not saying it's right, but it makes sense.

The company, the NIH, the bulls on this board and several others all agree there's a signal here worth pursuing, but the fact of the matter is that this drug has never been tested in humans for 6 months, and a lot of investors seem to ignore the huge question mark it puts on this whole thing.

I'm cautiously optimistic. The subgroup data looks promising but I think many of the bulls are too optimistic about the chance of success and too pessimistic about the value of good results.

Either way, we'll know for sure in only 2 months.